Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
RESEARCH TOOLSreports
MoonLake Immunotherapeutics (MLTX) Ownership - Who Owns MoonLake Immunotherapeutics?
257 Followers
MoonLake Immunotherapeutics (MLTX) Ownership Overview
66.52% Insiders
14.66% Mutual Funds
0.46% Other Institutional Investors
18.36% Public Companies and
Individual Investors
The ownership structure of MoonLake Immunotherapeutics (MLTX) stock is a mix of institutional, retail and individual investors. Approximately 15.12% of the company’s stock is owned by Institutional Investors, 66.52% is owned by Insiders and 18.36% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 10, 2023 | Bihua Chen >10% Owner | Bought | $3523868 |
| Oct 04, 2023 | Bihua Chen >10% Owner | Bought | $16799445 |
| Jul 05, 2023 | Bihua Chen >10% Owner | Bought | $40000000 |
| Jun 28, 2023 | Bihua Chen >10% Owner | Bought | $20535012 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $103991 | |
| Dec 31, 2023 | Bought | $205326 | |
| Dec 31, 2023 | Bought | $4976015 | |
| Dec 31, 2023 | Bought | $6039000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,068,007 | Institution | 1.78% | 46,607,825 | |
| 1,026,276 | Institution | 1.71% | 44,786,685 | |
| 948,031 | Institution | 1.58% | 41,372,073 | |
| 721,210 | Institution | 1.20% | 31,473,604 | |
| 674,911 | Institution | 1.13% | 29,453,116 | |
| 609,531 | Institution | 1.02% | 26,599,933 | |
| 404,294 | Institution | 0.67% | 17,643,390 | |
| 389,905 | Institution | 0.65% | 17,015,454 | |
| 293,516 | Institution | 0.49% | 12,809,038 | |
| 272,141 | Institution | 0.45% | 11,876,233 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,068,007 | Institution | 1.78% | 46,607,825 | |
| 1,026,276 | Institution | 1.71% | 44,786,685 | |
| 948,031 | Institution | 1.58% | 41,372,073 | |
| 721,210 | Institution | 1.20% | 31,473,604 | |
| 674,911 | Institution | 1.13% | 29,453,116 | |
| 609,531 | Institution | 1.02% | 26,599,933 | |
| 404,294 | Institution | 0.67% | 17,643,390 | |
| 389,905 | Institution | 0.65% | 17,015,454 | |
| 293,516 | Institution | 0.49% | 12,809,038 | |
| 272,141 | Institution | 0.45% | 11,876,233 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 61,581 | Institution | 0.10% | 3,093,214 | |
| 41,945 | Institution | 0.07% | 1,830,480 | |
| 23,191 | Institution | 0.04% | 1,012,055 | |
| 18,468 | Institution | 0.03% | 890,896 | |
| 16,000 | Institution | 0.03% | 698,240 | |
| 13,064 | Institution | 0.02% | 570,113 | |
| 10,795 | Institution | 0.02% | 542,233 | |
| 11,291 | Institution | 0.02% | 495,788 | |
| 9,405 | Institution | 0.02% | 453,697 | |
| 8,926 | Institution | 0.01% | 389,531 |
FAQ
Who Owns MoonLake Immunotherapeutics (MLTX)?
According to the latest TipRanks data, approximately 0.46% of the company's stock is held by institutional investors, 66.52% is held by insiders, and 18.36% is held by retail investors.
What percentage of MoonLake Immunotherapeutics (MLTX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.46% of MoonLake Immunotherapeutics (MLTX) stock is held by institutional investors.
What percentage of MoonLake Immunotherapeutics (MLTX) stock is held by retail investors?
According to the latest TipRanks data, approximately 18.36% of MoonLake Immunotherapeutics (MLTX) stock is held by retail investors.
Who owns the most shares of MoonLake Immunotherapeutics (MLTX)?
T. ROWE PRICE HEALTH SCIENCES FUND, INC. owns the most shares of MoonLake Immunotherapeutics (MLTX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.